South Korean researchers develop highly sensitive plasmonic nanomaterials for detecting cancer mutant genes in blood samples.

South Korean researchers Dr. Min-young Lee and Dr. Sung-gyu Park have developed a groundbreaking technology using plasmonic nanomaterials that can detect cancer mutant genes in blood samples with an unprecedented sensitivity of 0.000000001%. This method allows for early cancer diagnosis, monitoring treatment effectiveness, and personalized treatment plans, achieving 96% accuracy in detecting EGFR mutations in lung cancer patients. The research promises to enhance cancer management and reduce the need for invasive procedures.

September 06, 2024
4 Articles